Outcome | Time point | Control | Intervention | Crude DiD (95% CI) | Adjusted DiD (95% CI)* | ||
n | Mean (SD) | n | Mean (SD) | ||||
HDL cholesterol | Baseline | 90 | 1.4 (0.4) | 109 | 1.3 (0.4) | Ref | Ref |
12-month follow-up | 43 | 1.3 (0.3) | 31 | 1.2 (0.4) | 0.02 (−0.09 to 0.14) | 0.04 (−0.08 to 0.16) | |
LDL cholesterol | Baseline | 77 | 2.8 (0.9) | 108 | 2.9 (0.8) | Ref | Ref |
12-month follow-up | 25 | 2.9 (1.2) | 28 | 2.7 (0.7) | −0.28 (−0.71 to 0.15) | −0.26 (−0.67 to 0.15) | |
Triglyceride | Baseline | 92 | 1.7 (0.8) | 114 | 1.7 (0.8) | Ref | Ref |
12-month follow-up | 46 | 1.7 (0.8) | 32 | 1.5 (0.8) | −0.20 (−0.50 to 0.09) | −0.22 (−0.52 to 0.09) | |
Total cholesterol | Baseline | 93 | 4.9 (0.9) | 115 | 4.9 (1.0) | Ref | Ref |
12-month follow-up | 51 | 4.9 (1.2) | 33 | 4.6 (0.8) | −0.32 (−0.65 to 0.01) | −0.31 (−0.64 to 0.01) | |
Quality of life change (mean (SD)) | Baseline | 95 | 0.88 (0.12) | 120 | 0.87 (0.12) | Ref | Ref |
12-month follow-up | 72 | 0.87 (0.16) | 54 | 0.90 (0.11) | 0.04 (0.00 to 0.08) | 0.04 (0.00 to 0.08) |
*Adjusted for age, gender and state.
DiD, difference-in-differences; HDL, high-density lipoprotein; LDL, low-density lipoprotein.